4D Molecular Therapeutics, Inc. (FDMT) Institutional Ownership & Insider Trading
158 institutions reported holding 4D Molecular Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 28 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
FDMT4D Molecular Therapeutics, Inc.Follow FDMT — free
—
Price chart with a free account
- Market cap
- 779.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters158 institutions held 80.5% of the shares. Across filers that reported both quarters, shares held changed +14.3%.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 158 | 58 | +14.3% | 64 | 24 | 35 | 19 |
| Mar 26 | 152 | 51 | -5.1% | 34 | 23 | 50 | 23 |
| Dec 25 | 150 | 53 | +33.7% | 53 | 29 | 36 | 9 |
| Sep 25 | 127 | 40 | -1.1% | 27 | 27 | 42 | 19 |
| Jun 25 | 118 | 40 | -6.4% | 40 | 14 | 35 | 20 |
| Mar 25 | 123 | 43 | -7.1% | 30 | 17 | 56 | 35 |
| Dec 24 | 143 | 47 | -20.7% | 47 | 22 | 40 | 26 |
| Sep 24 | 138 | 58 | -2.0% | 52 | 20 | 43 | 24 |
4D Molecular Therapeutics, Inc. — questions
- Who owns 4D Molecular Therapeutics, Inc. stock?
- 158 institutions reported 4D Molecular Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: Jupiter Topco LLC (8.0%), RA CAPITAL MANAGEMENT, L.P. (7.0%), BlackRock, Inc. (6.3%).
- Are 4D Molecular Therapeutics, Inc. insiders buying or selling?
- 28 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from 4D Molecular Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.